| Bertrand Francis Jones, MD | |
|
305 W Pennsylvania Ave, Anaconda, MT 59711-1900 | |
| (406) 563-8500 | |
| (406) 563-8575 |
| Full Name | Bertrand Francis Jones |
|---|---|
| Gender | Male |
| Speciality | Orthopaedic Surgery |
| Location | 305 W Pennsylvania Ave, Anaconda, Montana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629189592 | NPI | - | NPPES |
| 1629189592 | Other | MT | NPI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 7428 (Montana) | Primary |
| Entity Name | Community Hospital Of Anaconda |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1205887924 PECOS PAC ID: 8123938974 Enrollment ID: O20030507000045 |
News Archive
Abacus Health Solutions has developed a new e-health enabled blood pressure monitoring and feedback system to improve health outcomes for hospital specialty clinics.
The Hospital of the University of Pennsylvania (HUP) has been accredited for the second time as a Magnet organization - the highest institutional honor granted for nursing excellence - from the American Nurses Credentialing Center's (ANCC) Magnet Recognition Program.
Biogen Idec and Facet Biotech Corporation today announced the publication of Phase 2 data showing that the addition of daclizumab to interferon beta (IFNβ) led to a significant reduction in the number of new or enlarged multiple sclerosis (MS) lesions when compared to IFNβ alone in patients with active relapsing forms of MS.
AGA Medical Holdings, Inc. today announced the settlement of a patent infringement lawsuit between the company and Medtronic, Inc. This dispute relates to the January 2007 patent infringement action against the company, filed by Medtronic, Inc., alleging that substantially all of AGA Medical's AMPLATZER® occluder and vascular plug devices infringe three of Medtronic's method and apparatus patents on shape memory alloy stents (U.S. Patent Nos. 5,190,546, 6,306,141 and 5,067,957, collectively known as "the Jervis patents").
Vertex Pharmaceuticals Incorporated today announced the initiation of a Phase 3b study called OPTIMIZE that will evaluate twice-daily (BID) dosing of a telaprevir-based combination regimen in people chronically infected with genotype 1 hepatitis C virus (HCV) who have not been treated previously. This is the first Phase 3 study to evaluate twice-daily dosing of a protease inhibitor for the treatment of hepatitis C. OPTIMIZE will not include a control arm of pegylated-interferon and ribavirin alone.
› Verified 8 days ago
| Entity Name | Community Hospital Of Anaconda |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538597703 PECOS PAC ID: 8123938974 Enrollment ID: O20031119000745 |
News Archive
Abacus Health Solutions has developed a new e-health enabled blood pressure monitoring and feedback system to improve health outcomes for hospital specialty clinics.
The Hospital of the University of Pennsylvania (HUP) has been accredited for the second time as a Magnet organization - the highest institutional honor granted for nursing excellence - from the American Nurses Credentialing Center's (ANCC) Magnet Recognition Program.
Biogen Idec and Facet Biotech Corporation today announced the publication of Phase 2 data showing that the addition of daclizumab to interferon beta (IFNβ) led to a significant reduction in the number of new or enlarged multiple sclerosis (MS) lesions when compared to IFNβ alone in patients with active relapsing forms of MS.
AGA Medical Holdings, Inc. today announced the settlement of a patent infringement lawsuit between the company and Medtronic, Inc. This dispute relates to the January 2007 patent infringement action against the company, filed by Medtronic, Inc., alleging that substantially all of AGA Medical's AMPLATZER® occluder and vascular plug devices infringe three of Medtronic's method and apparatus patents on shape memory alloy stents (U.S. Patent Nos. 5,190,546, 6,306,141 and 5,067,957, collectively known as "the Jervis patents").
Vertex Pharmaceuticals Incorporated today announced the initiation of a Phase 3b study called OPTIMIZE that will evaluate twice-daily (BID) dosing of a telaprevir-based combination regimen in people chronically infected with genotype 1 hepatitis C virus (HCV) who have not been treated previously. This is the first Phase 3 study to evaluate twice-daily dosing of a protease inhibitor for the treatment of hepatitis C. OPTIMIZE will not include a control arm of pegylated-interferon and ribavirin alone.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Bertrand Francis Jones, MD 401 W Pennsylvania Ave, Anaconda, MT 59711-1931 Ph: (406) 563-8500 | Bertrand Francis Jones, MD 305 W Pennsylvania Ave, Anaconda, MT 59711-1900 Ph: (406) 563-8500 |
News Archive
Abacus Health Solutions has developed a new e-health enabled blood pressure monitoring and feedback system to improve health outcomes for hospital specialty clinics.
The Hospital of the University of Pennsylvania (HUP) has been accredited for the second time as a Magnet organization - the highest institutional honor granted for nursing excellence - from the American Nurses Credentialing Center's (ANCC) Magnet Recognition Program.
Biogen Idec and Facet Biotech Corporation today announced the publication of Phase 2 data showing that the addition of daclizumab to interferon beta (IFNβ) led to a significant reduction in the number of new or enlarged multiple sclerosis (MS) lesions when compared to IFNβ alone in patients with active relapsing forms of MS.
AGA Medical Holdings, Inc. today announced the settlement of a patent infringement lawsuit between the company and Medtronic, Inc. This dispute relates to the January 2007 patent infringement action against the company, filed by Medtronic, Inc., alleging that substantially all of AGA Medical's AMPLATZER® occluder and vascular plug devices infringe three of Medtronic's method and apparatus patents on shape memory alloy stents (U.S. Patent Nos. 5,190,546, 6,306,141 and 5,067,957, collectively known as "the Jervis patents").
Vertex Pharmaceuticals Incorporated today announced the initiation of a Phase 3b study called OPTIMIZE that will evaluate twice-daily (BID) dosing of a telaprevir-based combination regimen in people chronically infected with genotype 1 hepatitis C virus (HCV) who have not been treated previously. This is the first Phase 3 study to evaluate twice-daily dosing of a protease inhibitor for the treatment of hepatitis C. OPTIMIZE will not include a control arm of pegylated-interferon and ribavirin alone.
› Verified 8 days ago
Dr. Jonathan B Pine, DO Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 305 W Pennsylvania Ave, Anaconda, MT 59711 Phone: 406-563-8571 Fax: 406-563-8523 | |
Carl Keeway Schillhammer, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 401 W Pennsylvania Ave, Anaconda, MT 59711 Phone: 406-563-8571 Fax: 406-563-8523 | |
Dr. Peter Paul Wendt, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 305 W Pennsylvania Ave, Anaconda, MT 59711 Phone: 406-563-8571 Fax: 406-563-8523 |